R&D Systems Inc. Tocris Bioscience Boston Biochem

BI 78D3

Cat. No. 3314

BI 78D3 C13H9N5O5S2 [883065-90-5]

Price and Availability

For BI 78D3 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]-3H-1,2,4-triazol-3-one

Biological Activity

Competitive c-Jun N-terminal kinase (JNK) inhibitor (IC50 = 280 nM) that displays > 100 fold selectivity over p38α and no activity at mTOR and PI-3K. Inhibits JNK interacting protein 1 (JIP1)-JNK binding (IC50 = 500 nM) and prevents JNK substrate phosphorylation. Blocks JNK-dependent Con A-induced liver damage and restores insulin sensitivity in a mouse model of type II diabetes.

Technical Data

M.Wt:
379.37
Formula:
C13H9N5O5S2
Solubility:
Soluble to 100 mM in DMSO and to 5 mM in ethanol
Purity:
>99 %
Storage:
Store at +4°C
CAS No:
883065-90-5

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Flight (2008) Getting rid of JNK. Nat.Rev.Drug Disc. 7 975.

Haas and Writer (2008) Block JNK at the dock. SCiBX 1 1.

Stebbins et al (2008) Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc.Natl.Acad.Sci.USA 105 16809.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: BI 78D3, supplier, Selective, competitive, JNK, inhibitors, MAPK, Signaling, Signalling, c-Jun, N-Terminal, Kinases, SAPKs, Stress-Activated, Protein, Mitogen-Activated, p38, BI78D3

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

Kinases Product Listing

Kinases Product Listing

Highlights over 350 products for kinase research. Request a copy or view PDF today.

divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Some of the most potent
kinase inhibitors all on one plate

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

divider line

Immunology Guide

Immunology Research Guide

Highlights over 150 products for immunology research. Request a copy or view PDF today.

divider line

MAPK Signaling Review

MAPK Signaling Review

Written by Elma Zaganjor and Melanie H. Cobb, leading experts. Request a copy or view PDF today.

divider line

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

Neuroprotection Poster

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.

divider line

New Product Guide

NPG

Highlights 140 new products added in the first half of 2014. Request a copy or view PDF today.

divider line

New Products in this Area

DBM 1285 dihydrochloride

p38 MAPK inhibitor; anti-inflammatory

SR 3576

Highly potent and selective JNK3 inhibitor

CEP 1347

Inhibitor of JNK signaling

IQ 3

Selective JNK3 inhibitor

Sign-up for new product e-alerts
divider line

Bio-Techne Events

Human Proteome Organisation World Congress 2014

Human Proteome Organisation World Congress 2014

October 5 - 8, 2014

Madrid, Spain